Parallax Volatility Advisers, L.P. Kymera Therapeutics, Inc. Transaction History
Parallax Volatility Advisers, L.P.
- $35.7 Billion
- Q1 2025
A detailed history of Parallax Volatility Advisers, L.P. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 135,600 shares of KYMR stock, worth $6.03 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
135,600Holding current value
$6.03 Million% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding KYMR
# of Institutions
181Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$298 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$287 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$267 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$266 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$232 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.43B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...